This protocol is judged by an institutional review board, an impartial team that testimonials any scientific trials involving humans. If a review involves a Timetable I drug, when the board approves the protocol as moral, the researchers need to submit an application for an investigational new drug (IND) quantity through the FDA.This article inclu